severe immune disorders. Both their spleens and lymph nodes are bereft of B lymphocytes, undermining their capacity to form germinal centers (24, 25) . These observations strongly suggest that members of the Rel/NF-κB family perform nonoverlapping functions, and that a loss-of-function mutation of a Rel/NF-κB gene may not be fully compensated for by other genes of this family.
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory disease of the CNS that has long been used as an animal model for human multiple sclerosis. Development of EAE requires coordinated expression of a number of genes involved in the activation, differentiation, and effector functions of inflammatory cells. To investigate the roles of Rel/NF-κB in CNS inflammation, we studied EAE in mice deficient in NF-κB1 and c-Rel. We found that mice deficient in NF-κB1 are partially resistant to the development of EAE and are unable to support Th2 cell differentiation (26) . This is consistent with a recent report by Das et al. that Gata3-mediated Th2 cell differentiation is blocked in NF-κB1-deficient mice, and that NF-κB1-deficient T cells are unable to differentiate into a Th2 lineage even under Th2-inducing conditions (27) . We report here that c-Rel-deficient mice are completely defective in their Th1 responses, whereas their Th2 responses are enhanced. We will present evidence that c-Rel selectively regulates Th1 cell differentiation through IL-12 and IFN-γ, but not T-bet. T-bet is a newly described transcription factor specific for Th1 cells (28) . We will then propose a new paradigm of Th cell differentiation in the context of Rel/NF-κB regulation of autoimmune inflammation.
Methods
Mice. C57BL/6 mice that carry c-Rel gene mutation were generated by inserting the neo r cassette into the fifth exon of the c-Rel gene as described previously (18) . Normal C57BL/6, B6;129, and NF-κB1-deficient (NF-κB1 -/-) B6;129 mice were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). All mice were housed in the University of Pennsylvania Animal Care Facilities under pathogen-free conditions.
Bone marrow chimeric mice were generated by either irradiating c-Rel +/+ or c-Rel -/-C57BL/6 mice with two doses of 5 Gy spaced 3 hours apart, followed by intravenous injection of 10 7 bone marrow cells from CD45.1 congenic C57BL/6 mice; or by transferring c-Rel +/+ or c-Rel -/-bone marrow into irradiated CD45.1 congenic C57BL/6 mice. Repopulation of the immune system was monitored by flow cytometric analysis of the blood using anti-mouse CD45.1 Ab conjugated to phycoerythrin and anti-mouse CD45.2 Ab conjugated to FITC (BD Pharmingen, San Diego, California, USA). In the chimeric mice, approximately 90% of the T cells and more than 95% of the B cells and myeloid cells were derived from donor bone marrow. Mice were immunized 8-9 weeks after bone marrow transfer as described below.
Induction and clinical evaluation of EAE. For induction of EAE, mice received a subcutaneous injection in the flank of 300 µg myelin oligodendrocyte glycoprotein (MOG) 38-50 peptide in 0.1 ml PBS emulsified in an equal volume of CFA containing 4 mg/ml of Mycobacterium tuberculosis H37RA (Difco Laboratories, St. Louis, Missouri, USA), and an intravenous injection of 200 ng pertussis toxin in 0.1 ml PBS. A second injection of pertussis toxin (200 ng per mouse) was given 48 hours later. Mice were examined daily for signs of EAE and scored as follows: 0, no disease; 1, tail paralysis; 2, hind limb weakness; 3, hind limb paralysis; 4, hind limb plus forelimb paralysis; 5, moribund or dead.
Antigens, Ab's, recombinant cytokines, and ELISA. Mouse MOG38-50 peptide was synthesized using Fmoc solidphase methods, and purified by HPLC by Research Genetics (Huntsville, Alabama, USA). Pertussis toxin was purchased from List Biological Laboratories Inc. (Campbell, California, USA). The following reagents were purchased from BD Pharmingen: purified rat anti-mouse IL-2, IL-4, IL-10, IL-12 p40, and IFN-γ mAb's; recombinant mouse IL-2, IL-4, IL-10, IL-12, and IFN-γ. Quantitative ELISA for IL-2, IL-4, IL-10, IL-12 p40, and IFN-γ was performed using paired mAb's specific for corresponding cytokines per manufacturer recommendations.
Isolation of T cells, antigen-presenting cells, astrocytes, and microglia. CD4 + T cells were isolated from spleen of naive C57BL/6 mice using the autoMACS magnetic cell sorter (Miltenyi Biotec, Auburn, California, USA) following sequential incubation of splenocytes with rat anti-mouse CD4 mAb (clone GK1-5; American Type Culture Collection, Rockville, Maryland, USA) and goat anti-rat IgG magnetic beads. More than 95% of the cells isolated in this manner are CD4 + as determined by flow cytometry. Splenic antigen-presenting cells (APCs) were prepared from the same cell suspension by depleting lymphocytes using mAb's against mouse CD4, CD8 (clone 2.43; American Type Culture Collection), and CD19 (clone 1D3; BD Pharmingen) with the autoMACS cell sorter.
For IL-12 secretion experiments, a collagenase-digested splenocyte suspension was first incubated for 2 hours at 37°C. Cells in the suspension were discarded and the culture was allowed to continue for another 16 hours. Only dendritic cell-enriched (DC-enriched) APCs in the suspension were harvested and used for the experiment. To prepare APCs from bone marrow, femurs and tibiae were surgically removed and the marrow was flushed with complete RPMI medium. After removing erythrocytes, bone marrow cells were cultured at 10 6 /ml in complete RPMI medium containing 3 ng/ml of murine GM-CSF and 5.5 ng/ml of murine IL-4 (R&D Systems Inc., Minneapolis, Minnesota, USA). Five days later, cells in suspension were harvested, washed, and used for IL-12 experiments. Microglia and astrocytes were prepared from newborn mice as described by Suzumura et al. with minor modifications (29) . Briefly, mixed glial cells were first cultured in complete DMEM at 10 6 cells/ml. After 8-10 days, microglia growing on the surface of adherent astrocytes were harvested by shaking for 1.5-2 hours at 260 rpm. The remaining cell monolayers were shaken at 100 rpm for another 24 hours to remove contaminating oligodendrocytes. Astrocytes were then detached and collected using 0.25% trypsin-EDTA.
Semiquantitative PCR analysis of p19, p35, and p40 mRNA in DCs. DC-enriched APCs were cultured with or without 1-5 µg/ml of LPS (Sigma-Aldrich, St. Louis, Missouri, USA) for 5 hours. Total RNA was isolated using Trizol (Invitrogen Corporation, Carlsbad, California, USA), primed with random hexamers, and reverse transcribed using Moloney murine leukemia virus reverse transcriptase. Semiquantitative PCR of IL-12 p40, IL-12 p35, IL-23 p19, and β-actin were performed using the following oligonucleotides: IL-12 p40, 5′-AAGTTCTCTC-CTCTTCCCTGTCGC-3′ and 5′-TCTTGTGGAGCAGCA-GATGTGAG-3′ (which result in a 423-bp product); IL-12 p35, 5′-CAATCACGCTACCTCCTCTTTTTG-3′ and 5′-CTCCCTCTTGTTGTGGAGAAGT-C-3′ (which result in a 308-bp product); IL-23 p19, 5′-ACCCACAAGGACTCAAGGA-CAAC-3′ and 5′-TGCCCTTCACGCAAAA-CAAAAC-3′ (which result in a 476-bp product); β-actin, 5′-GTGGGCCGCTCTAGGCA-CCAA-3′ and 5′-CTCTTTGATGTCACGCAC-GATTTC-3′ (which result in a 540-bp product). PCR products were analyzed by agarose gel electrophoresis.
Western blot. Nuclear lysates of T cells were fractionated by 10% PAGE and transferred onto a nitrocellulose membrane. After blocking with 5% nonfat milk, 10 mM Tris, 100 mM NaCl, and 0.1% Tween 20, the membrane was incubated sequentially with polyclonal goat anti-T-bet Ab's and horseradish peroxidase-labeled anti-goat IgG (Santa Cruz Biotechnology Inc., Santa Cruz, California, USA). Color was developed using SuperSignal chemiluminescent substrates (Pierce Chemical Co., Rockford, Illinois, USA).
Statistical analysis. Disease severity, day of onset, and cytokine concentrations were analyzed by ANOVA. Disease scores were analyzed by Mann-Whitney test.
Results

c-Rel-deficient mice are resistant to EAE.
To study the roles of c-Rel in the development of EAE, we immunized normal and c-Rel-deficient mice (18) with MOG38-50 peptide and monitored the disease by both physical examination and histochemistry. Figure 1a illustrates typical disease courses in control and c-Rel-deficient C57BL/6 mice. EAE developed in all control mice, starting approximately 13 days after immunization and reaching a maximal clinical score of 3.7 three weeks later. The disease took a chronic progressive course with a mortality rate of approximately 25%. By contrast, in the c-Rel-deficient group, only 16% of the mice developed symptoms of EAE. Disease severity was also dramatically reduced in this group, and the onset of disease was delayed by approximately 12 days ( Figure 1a , Table 1 ).
Consistent with these clinical findings, histological examination of the CNS revealed dramatic differences between the two groups. In the control group, multiple inflammatory foci were observed in the cerebrum, cerebellum, brain stem, and spinal cord, with severe demyelination in the white matter (Figure 2b ). By contrast, no lesions or demyelination were detected in the CNS of most c-Rel-deficient mice that showed no symptoms of EAE (Figure 2a) . In those c-Rel-deficient mice that did develop EAE, we observed inflammatory infiltrates and demyelination similar to those found in the control mice. Remarkably, c-Rel deficiency in bone marrowderived cells alone was sufficient to inhibit EAE ( Figure  1b) , whereas c-Rel deficiency in cells not derived from bone marrow had no effect on EAE (Figure 1c) . Taken together, these results indicate that c-Rel expressed by the immune system plays an indispensable role in the development of autoimmune inflammation in the CNS.
c-Rel and NF-κB1 regulate different types of T cell responses in vivo.
Resistance to EAE in c-Rel-deficient mice can be due either to the inability of myelin-specific T cells to differentiate into effector T cells in the periphery or to the inability of differentiated effector T cells to induce demyelinating inflammation in the CNS, or both. To address this issue, we examined whether activation and differentiation of myelin-specific T cells were normal in c-Rel-deficient animals. Splenocytes were collected from both control and c-Rel-deficient mice preimmunized with MOG peptide and tested in vitro for their cytokine production and proliferation in response to the specific peptide. As shown in Figure 3 , splenocytes of control animals proliferated vigorously in response to MOG peptide and produced both Th1 (IL-2 and IFN-γ) and Th2 (IL-4) cytokines. By contrast, splenocytes from c-Reldeficient animals produced no detectable IFN-γ regardless of the MOG concentration in the culture. IL-2 secretion and cell proliferation were also reduced in the c-Rel -/-cultures (Figure 3) . Unexpectedly, IL-4 production was dramatically increased in these cultures. Since IFN-γ can potentially inhibit the differentiation of Th2 cells, it is possible that the increase in IL-4 production is caused by the decrease in IFN-γ secretion.
These results strongly suggest that Th1, but not Th2 pathway of T cell differentiation is blocked in c-Rel -/-mice. This is in startling contrast to the Th2 deficiency observed in mice deficient in NF-κB1, another member of the Rel/NF-κB family (26, 27) . As shown in Figure 4 , NF-κB1 -/-mice are defective primarily in their IL-4 secretion, whereas their IFN-γ production is relatively normal. Das et al. recently demonstrated that this deficiency in IL-4 production is caused by selective blockade of Gata3-mediated Th2 cell differentiation in NF-κB1 -/-mice; Th1 cell differentiation is not affected by NF-κB1 deficiency (27) . Also shown in Figure 4 
Figure 2
Histological profiles of spinal cords. Mice were treated as described in Figure 1a and perfused with PBS and phosphate-buffered formalin at the end of the experiment. Spinal cords were harvested, fixed in 10% formalin, and embedded in paraffin. Five-micrometer-thick paraffin sections were stained with both Luxol fast blue and cresyl violet. 
Figure 3
Complete blockade of Th1 IFN-γ response in c-Rel-deficient mice. Normal (black bars) and c-Rel -/-(white bars) mice were treated as in Figure 1a and sacrificed 36 days after immunization. Splenocytes (7.5 × 10 5 /ml) were cultured in complete DMEM with or without 5-25 µg/ml of MOG38-50 peptide. Culture supernatants were collected 40 hours later and tested for cytokines by ELISA. For proliferation assays, cells were pulsed with 3 H-thymidine at 48 hours and radioactivity was determined 16 hours later. Results are shown as mean + SD from a total of 12 mice (6 mice per group). The differences between the two groups are statistically significant for all parameters (P < 0.01). The experiments were repeated twice with similar results.
B6;129 mice. It is to be noted that although the genetic backgrounds of these mice are not identical, they mounted similar Th1 and Th2 responses following immunization with MOG peptide. Taken together, these results indicate that c-Rel and NF-κB1 preferentially regulate Th1 and Th2 cell responses, respectively.
c-Rel-deficient cells are defective in IL-12 production. Activation and differentiation of T cells require antigen presentation and costimulation by APCs. c-Rel may regulate T cell activation and differentiation directly through T cells or indirectly through APCs.
To investigate the latter possibility, we examined whether the expression of APC molecules required for T cell activation and differentiation are normal in c-Rel-deficient mice. To our initial surprise, we found no significant differences between normal and c-Rel-deficient APCs in their expression of B7-1, B7-2, class I, and class II MHC molecules (as determined by flow cytometry), with or without LPS stimulation (our unpublished observations). Importantly, we found that c-Rel-deficient cells produced significantly smaller amounts of IL-12 p40, a cytokine essential for Th1 cell differentiation. Figure 5 is representative of such experiments. APCs derived from normal spleen or bone marrow, and microglia and astrocytes derived from CNS all produced significant amounts of IL-12 p40 upon stimulation with LPS. By contrast, much-reduced amounts of IL-12 p40 were produced by c-Rel-deficient cells of all these lineages. Similar reductions in IL-12 p40 production were also observed in splenocyte cultures stimulated with MOG, although the total amounts of IL-12 in the latter cultures were significantly lower than in LPS-treated cultures (our unpublished observations). Since IL-12 p40 can pair with either p35 (to form IL-12) or p19 (to form IL-23), we examined the gene expression of p35 and p19 as well as p40 by PCR. As shown in Figure 6a , the expression of each of these three genes was markedly reduced in c-Rel -/-APCs. As shown in Figure  6b , T-bet is expressed by both Th0 and Th1 cells. These results suggest that c-Rel-deficient T cells are able to respond to both T cell receptor (anti-CD3 mAb) and costimulatory (anti-CD28 mAb) signals and are not intrinsically defective in their activation program. In the presence of TCR and CD28 signals, c-Rel-deficient T cells can become activated and mount significant Th2 and IL-2 responses as normal T cells do (Figure 8) . However, c-Rel-deficient T cells do suffer from a severe functional defect: they are unable to produce IFN-γ even in the presence of CD28 stimulation, suggesting that c-Rel may selectively regulate the maturation of IFN-γ-producing T cells. 
c-Rel -/-T cells fail to differentiate into Th1 cells even under
Figure 6
Regulation of gene expression by c-Rel. (a) p35, p40, and p19 expression in APCs. DC-enriched APCs from normal and c-Rel-deficient C57BL/6 mice were cultured with or without (-) LPS for 5 hours as described in Figure 5 legend. Total RNA was extracted, and gene expression was determined by RT-PCR as described in Methods. (b) T-bet expression in T cells. CD4 + T cells were isolated and treated as described in Figure 9 , and their nuclear extracts were prepared 48 hours after the second stimulation. T-bet expression was determined by Western blot as described in Methods. 
Figure 8
Selective blockade of IFN-γ production in c-Rel-deficient T cells. Normal and c-Rel-deficient CD4 + T cells were purified and cultured at 10 6 cells/ml with or without plate-bound anti-CD3 mAb (2 µg/ml) and anti-CD28 mAb (2 µg/ml). Culture supernatants were collected 48 hours later and cytokine concentrations were determined by ELISA. Results are representative of two experiments.
Figure 9
CD4 + T cell differentiation in vitro. Purified CD4 + T cells were cultured at 10 6 /ml in the presence of IL-2 (50 U/ml), plate-bound anti-CD28 mAb (2 µg/ml), and anti-CD3 mAb (2 µg/ml) without (a, Th0, left column) or with (b, Th1, right column) IL-12 (10 ng/ml) and anti-IL4 mAb (20 ng/ml). Five days later, cells were washed and restimulated with plate-bound anti-CD3 mAb and anti-CD28 mAb for up to 72 hours. Culture supernatants were collected at 24, 48, and 72 hours, and cytokine concentrations were determined by ELISA. Results are representative of two experiments. Only those bars for SEM that are wider than the symbol are shown.
Although it is clear that MOG and adjuvant activate specific T cells by generating both the T cell receptor (the first) and the costimulatory (the second) signals, the transcriptional elements involved in this process are poorly understood. Data presented here suggest that c-Rel may be one of the transcriptional regulators that are important for this process. In the absence of c-Rel, autoreactive T cells may not be fully activated and may not effectively differentiate into Th1-type cells; therefore, severe autoimmune encephalomyelitis may not develop even with active immunization with myelin antigen and adjuvant. It is to be noted that experiments reported here do not directly address the question of whether c-Rel plays a role in the effector stage of EAE. Because differentiation of autoreactive Th1 cells is significantly compromised in c-Rel-deficient mice, it is difficult to examine the functions of c-Rel-deficient effector cells in EAE. It is also to be noted that although c-Rel is expressed by various neural cells (6) (7) (8) (9) and its deficiency significantly affects IL-12 production by astrocytes and microglia (see Figure 5 ), c-Rel expressed by the CNS may not affect the progression of autoimmune inflammation ( Figure  1c ). Consistent with this view, a recent report by Campbell et al. suggests that c-Rel may not be involved in the later stages of synovial inflammation in an animal model of rheumatoid arthritis (38) . Thus, the roles of c-Rel in autoimmune inflammation may be mediated primarily through its effect on immune cells.
